You are here: Industry Insights > Drug

News List

Transmission Risks Up for HIV-Positive Injection Drug Users drugs
August 02, 2019
HIV-positive individuals who inject drugs are more likely to have a detectable viral load and engage in high-risk sexual behaviors...
Indian drug makers looking to expand in Chinese pharma industry europeanpharmaceuticalreview
August 02, 2019
According to a new report, pharma companies in India are increasingly entering the Chinese pharma industry through joint ventures.
FTC investigates contracts regarding autoimmune disease drug, Remicade europeanpharmaceuticalreview
August 02, 2019
The US Federal Trade Commission is investigating whether Johnson and Johnson violated antitrust laws with its medication, Remicade.
Ontario and Quebec against plan to lower Canadian drug prices europeanpharmaceuticalreview
August 02, 2019
The two Canadian provinces have expressed concern over the new draft regulations, claiming that the reforms would delay patient access to medicines.
Drug Duo May Be an Advance Against a Common Leukemia drugs
August 01, 2019
A two-drug combo helps patients with a common form of leukemia survive longer than the current standard of care, a new clinical trial finds.
AstraZeneca and Novartis set to lose out from US drug prices reforms europeanpharmaceuticalreview
July 31, 2019
A report has suggested that the drug price reforms in the US will affect AstraZeneca and Novartis negatively, but Novo could benefit.
Heartburn Drugs Might Bring Allergy Woes drugs
July 31, 2019
There are numerous drugs to treat digestive woes caused by heartburn or stomach ulcers. But solving one health problem may be causing another.
$70 Million Settlement Reached in Generic Drug Delay Case drugs
July 31, 2019
Three drug companies will pay a total of nearly $70 million to California to settle charges of delaying the sale of generic drugs to keep brand-name drug prices high...
Mustang Bio’s AML Treatment Receives Orphan Drug Designation contractpharma
July 31, 2019
MB-102 (CD123 CAR T) evaluated to treat AML and BPDCN.
Lifesaving Drug for Infants Costs $2.1 Million a Dose drugs
July 30, 2019
Its extremely high price tag means that a lifesaving medication to treat young children with spinal muscular atrophy is simply too expensive for most families.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 49 50 Next page